Abiopharma

JUPITER NEUROSCIENCES, INC. (JUNS)

Symbol	JUNS
Name	JUPITER NEUROSCIENCES, INC.
Sector	HEALTH CARE
Region	North America
Industry	Biotechnology: Pharmaceutical Preparations
Address	1001 NORTH US HWY 1,SUITE 504, JUPITER, Florida, 33477, United States
Telephone	(561) 406-6154
Fax	—
Email	—
Website	https://www.jupiterneurosciences.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001679628
Description	Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL , has many potential indications of use for rare diseases, which of we primarily are targeting Mucopolysaccharidoses Type 1, Friedreichs Ataxia, and MELAS as well as ALS which is in an early development stage. In the larger disease areas, we are primarily targeting Mild Cognitive Impairment/early Alzheimers disease with TBI/concussions and Covid-19 in early development stages. Based on available scientific literature, we believe that JOTROL is the first and only resveratrol product in the world that delivers a therapeutically effective dose of resveratrol in the blood stream without causing gastrointestinal side effects. Additional info from NASDAQ: Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL , has many potential indications of use for rare diseases, which of we primarily are targeting Mucopolysaccharidoses Type 1, Friedreichs Ataxia, and MELAS as well as ALS which is in an early development stage. In the larger disease areas, we are primarily targeting Mild Cognitive Impairment/early Alzheimers disease with TBI/concussions and Covid-19 in early development stages. Based on available scientific literature, we believe that JOTROL is the first and only resveratrol product in the world that delivers a therapeutically effective dose of resveratrol in the blood stream without causing gastrointestinal side effects.

2026-08-05 12:00

Jupiter Neurosciences, Inc. Announces Reverse Stock Split

2026-07-29 10:09

New Form 424B3 - JUPITER NEUROSCIENCES, INC. Filed: 2026-07-29 AccNo: 0001493152-26-035121 Size: 41 KB

2026-07-28 21:20

(99% Neutral) JUPITER NEUROSCIENCES, INC. (JUNS) Provides Business Update

2026-07-27 13:00

(99% Neutral) JUPITER NEUROSCIENCES, INC. (JUNS) Announces Business Combination

2026-07-27 10:06

New Form 424B3 - JUPITER NEUROSCIENCES, INC. Filed: 2026-07-27 AccNo: 0001493152-26-034726 Size: 61 KB

2026-07-22 22:13

New Form 3 - JUPITER NEUROSCIENCES, INC. Filed: 2026-07-22 AccNo: 0001493152-26-034284 Size: 18 KB

2026-07-21 20:05

(99% Neutral) JUPITER NEUROSCIENCES, INC. (JUNS) Announces Business Combination

2026-07-21 17:08

New Form 424B3 - JUPITER NEUROSCIENCES, INC. Filed: 2026-07-21 AccNo: 0001493152-26-034082 Size: 419 KB

2026-07-21 11:13

Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million

2026-07-08 07:03

New Form EFFECT - JUPITER NEUROSCIENCES, INC. Filed: 2026-07-07 AccNo: 9999999995-26-002213 Size: 1 KB

No clinical trials found for this company.

No clinical products found for this company.